← Back to Search

Healthy Volunteers for Healthy Subjects

N/A
Waitlist Available
Led By Yamini Bynagari, PhD
Research Sponsored by Haemonetics Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
• Adult volunteers (18 years of age and older) who self-identify as being in general good health.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up outcome measure from the single blood draw was assessed within 2 hours of blood draw. unit of measurement was minutes.
Awards & highlights
No Placebo-Only Group

Summary

This trial holds minimal risk to the trial volunteers and consists of obtaining whole blood via venipuncture to perform coagulation parameter measurements to define a Normal Reference Range. Written consent to participate in the study will be obtained prior to volunteer screening per site procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~outcome measure from the single blood draw was assessed within 2 hours of blood draw. unit of measurement was mm.
This trial's timeline: 3 weeks for screening, Varies for treatment, and outcome measure from the single blood draw was assessed within 2 hours of blood draw. unit of measurement was mm. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
CFFH-MA TEG Parameter
CK-MA TEG Parameter
CK-R TEG Parameter
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Healthy VolunteersExperimental Treatment2 Interventions
Adult volunteers (18 years of age and older) who self-identify as being in general good health.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TEG 6s Citrated K, KH, RTH, and FFH Cartridge
2021
N/A
~190
Clauss Fibrinogen
2021
N/A
~520

Find a Location

Who is running the clinical trial?

Haemonetics CorporationLead Sponsor
19 Previous Clinical Trials
10,952 Total Patients Enrolled
Machaon DiagnosticsIndustry Sponsor
ClinStatDeviceUNKNOWN
1 Previous Clinical Trials
338 Total Patients Enrolled
~43 spots leftby Nov 2025